Posts Tagged ‘patent expiration’

Drug Patent Expirations for the Week of May 19, 2019

VESICARE (solifenacin succinate) Astellas Patent: 6,017,927 Expiration: May 19, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…


Drug Patent Expirations for the Week of May 19, 2019

VESICARE (solifenacin succinate) Astellas Patent: 6,017,927 Expiration: May 19, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…


New patent expiration for Astellas drug VESICARE

Annual Drug Patent Expirations for VESICARE Vesicare is a drug marketed by Astellas and is included in one NDA. It is available from five suppliers. There is one patent protecting…
The post New patent expiration for Astellas drug VESICARE appeared firs…


Drug Patent Expirations for the Week of May 19, 2019

VESICARE (solifenacin succinate) Astellas Patent: 6,017,927 Expiration: May 19, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…


Patent delisted for Allergan drug SANCTURA XR

Annual Drug Patent Expirations for SANCTURA+XR Sanctura Xr is a drug marketed by Allergan and is included in one NDA. There are five patents protecting this drug and one Paragraph…
The post Patent delisted for Allergan drug SANCTURA XR appeared first o…


Patent delisted for Allergan drug SANCTURA XR

Annual Drug Patent Expirations for SANCTURA+XR Sanctura Xr is a drug marketed by Allergan and is included in one NDA. There are five patents protecting this drug and one Paragraph…
The post Patent delisted for Allergan drug SANCTURA XR appeared first o…


Patent delisted for NOVO drug FIASP

Annual Drug Patent Expirations for FIASP Fiasp is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are fourteen patents protecting…
The post Patent delisted for NOVO drug FIASP appeared first on DrugPatentWat…


Patent delisted for NOVO drug FIASP FLEXTOUCH

Annual Drug Patent Expirations for FIASP+FLEXTOUCH Fiasp Flextouch is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are fourteen patents…
The post Patent delisted for NOVO drug FIASP FLEXTOUCH appeared fir…


New patent expiration for Pfizer drug EXUBERA

Annual Drug Patent Expirations for EXUBERA Exubera is a drug marketed by Pfizer and is included in one NDA. There are three patents protecting this drug. This drug has three…
The post New patent expiration for Pfizer drug EXUBERA appeared first on Drug…


New patent expiration for Astrazeneca Pharms drug EPANOVA

Annual Drug Patent Expirations for EPANOVA Epanova is a drug marketed by Astrazeneca Pharms and is included in one NDA. There are nine patents protecting this drug. This drug has…
The post New patent expiration for Astrazeneca Pharms drug EPANOVA appea…


Do NOT follow this link or you will be banned from the site!